New Continuing Medical Education (CME)-Certified Case Study Launched on AestheticEnhance.org

Professional Postgraduate Services® (PPS®), renowned for its award-winning healthcare websites, recently launched a CME-certified interactive case study on AestheticEnhance.org, a new educational resource for the clinician on aesthetic enhancement.

Secaucus, NJ (PRWEB) July 13, 2007 -- Professional Postgraduate Services® (PPS®), renowned for its award-winning healthcare websites, recently launched a CME-certified interactive case study on Aesthetic Enhance, a new educational resource for the clinician on aesthetic enhancement. The case study, Combining Botulinum Toxin Type A, Fillers, and Energy-Based Treatments: A Rational Approach to the Sequencing of Treatments, was authored by AestheticEnhance.org Steering Committee Member Kevin C. Smith, MD, FRCP(C), a dermatologist in private practice in Niagara Falls, Ontario, Canada.

This innovative case study, awarding 0.5 AMA PRA Category 1 Credit™, allows participants to play the role of physician by "meeting" a patient and gleaning insight into his/her medical history and presentation. Thereafter, they encounter a series of questions regarding appropriate diagnosis, treatment, and management based on current clinical standards of practice. For each decision selected, expert commentary from the physician-author is provided to support or negate the participants' choices After completing this activity, participants should be able to discuss the appropriate sequence of procedures as part of a single-session treatment plan involving the combination of botulinum toxin type A, dermal fillers, and energy-based devices for aesthetic enhancement of the face and neck; address the safety considerations inherent with combining various treatment procedures in a single session for aesthetic enhancement of the face and neck; and devise a patient-retention technique that underscores the nature and degree of patients' improvement with various aesthetic-enhancement procedures.

Interactive case studies offered from PPS are an effective educational method for reinforcing appropriate diagnosis and management of patients through the various stages of care. Moreover, they afford participants the opportunity to practice skills affecting clinical practice and healthcare outcomes.

AestheticEnhance.org is a premier, authoritative resource for the latest clinical information, tools, patient education, and CME on aesthetic enhancement. Among other notable areas, the website proudly announces updates to the following features:

- Current Literature: Our ever-expanding library continues to grow with new selections on botulinum toxin type A, treatment of hyperhidrosis, and fractional photothermolysis. Expert commentary from Steering Committee Member Julius W. Few, MD, FACS, is also featured.
- Ask The Expert: Each month, national and international thought leaders answer user-submitted questions. This month, Steering Committee Member Mark L. Jewell, MD, addresses 9 intriguing new questions.
- Coming Soon: A comprehensive, self-study course on dermal fillers.

AestheticEnhance.org was developed with funding through an educational grant from Allergan, Inc.

Professional Postgraduate Services® (PPS) is a business unit of KnowledgePoint360 Group LLC, a leading healthcare information company.

Professional Postgraduate Services® (PPS) develops medical education activities designed to meet the needs of practicing physicians. PPS, working with medical leaders, designs and implements effective programs to meet specific educational objectives. Our overall goal is to conduct activities that will modify physician behavior in such a way as to have a positive impact on patient care and quality of life. Program formats are based on careful evaluation of message complexity, goals, audience needs, and budget, always taking advantage of proven training methodologies and interactivity. PPS develops medical education programs consistent with the Essentials and Standards of the Accreditation Council for Continuing Medical Education as well as guidelines established by the AMA, PhRMA, and FDA.

# # #